PRESCRIBING · PART D · 2024
Total Rx claims
477
Beneficiaries
—
Total drug cost
$225K
Distinct drugs
13
Brand share
85.5%
Top prescribed drugs
Insulin Glargine,hum.Rec.Anlog82 claims
Empagliflozin51 claims
Pen Needle, Diabetic35 claims
Metformin Hcl35 claims
Insulin Glargine,hum.Rec.Anlog34 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
85.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity
CROSS-REFERENCE